# CSHL 2022 Neurodegenerative Diseases: Biology & Therapeutics Conference

> **NIH NIH R13** · COLD SPRING HARBOR LABORATORY · 2022 · $30,790

## Abstract

ABSTRACT
Neurodegenerative Diseases: Biology & Therapeutics
November 30 - December 3, 2022
This proposal seeks support for the biennial conference on Neurodegenerative Diseases:
Biology & Therapeutics, from November 30 – December 3, 2022 at Cold Spring Harbor
Laboratory (CSHL). The meeting brings together scientists who investigate both basic and
translational aspects of neurodegenerative disorders such as Alzheimer's disease, Parkinson's
disease, and amyotrophic lateral sclerosis. For many of these disorders, the molecular
pathways of the disease processes remain unclear and thus few biomarkers have been
identified. For other disorders, existing treatments are designed primarily to provide relief from
symptoms without addressing the biology underlying degenerative processes. Translational
research is therefore needed to develop and validate novel diagnostic strategies as well as new
therapeutics that might halt or stem disease progression, rather than simply alleviate symptoms.
The conference will advance knowledge in neurodegeneration by providing a forum where
scientists from distinct laboratories and institutions, both academic and industry, can exchange
findings, ideas, and seek collaborations. It will include sessions on convergent and divergent
pathways in neurodegenerative diseases, glial biology, therapeutic strategies, APOE and lipid
metabolism, cell biology, and protein homeostasis. For human studies seeking new treatments
for neurodegeneration to be informative, it is essential for scientists who research different
aspects of those treatments to meet regularly in a setting like CSHL to exchange data and
ideas. The 2022 CSHL meeting on Neurodegenerative Diseases: Biology & Therapeutics will
build on the successes of prior CSHL meetings to assemble an international gathering of top
scientists, discuss new developments in the field, and catalyze innovative research
collaborations, all of which will ultimately accelerate the pace of discovery.

## Key facts

- **NIH application ID:** 10539022
- **Project number:** 1R13AG079571-01
- **Recipient organization:** COLD SPRING HARBOR LABORATORY
- **Principal Investigator:** DAVID J. STEWART
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $30,790
- **Award type:** 1
- **Project period:** 2022-08-15 → 2023-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10539022

## Citation

> US National Institutes of Health, RePORTER application 10539022, CSHL 2022 Neurodegenerative Diseases: Biology & Therapeutics Conference (1R13AG079571-01). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10539022. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*